Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Not Confirmed
Not Confirmed
03-05 April, 2025
Not Confirmed
Not Confirmed
05-09 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Industry Trade Show
Not Confirmed
03-05 April, 2025
Industry Trade Show
Not Confirmed
05-09 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
31 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/31/3052293/0/en/Aprea-Therapeutics-Announces-Dosing-of-Patient-with-HPV-Head-and-Neck-Squamous-Cell-Carcinoma-HNSCC-in-Ongoing-ACESOT-1051-Trial.html
25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048724/0/en/Aprea-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-a-Business-Update.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040566/0/en/Aprea-Therapeutics-Announces-Agreement-with-MD-Anderson-Cancer-Center-to-Explore-APR-1051-as-a-Potential-Treatment-for-Head-and-Neck-Squamous-Cell-Carcinoma-HNSCC.html
05 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/05/3021110/0/en/Aprea-Therapeutics-Announces-Strategic-IP-Portfolio-Evolution-in-DNA-Damage-Response-DDR-Cancer-Therapeutics.html
11 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/11/2995400/0/en/Aprea-Therapeutics-Announces-Twice-Daily-BID-Dosing-of-Patients-in-ABOYA-119-Clinical-Trial-of-ATRN-119-to-Potentially-Optimize-Clinical-Outcomes-and-Strengthen-Clinical-Path-Forwa.html
07 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/07/2976642/0/en/Aprea-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
ABOUT THIS PAGE